Sexual Health and Hormone Replacement Therapy

Cyproterone acetate, a 17-hydroxyprogesterone acetate derivative, is a very potent one and is widely used.

• Hormonal imbalance can cause decreased libido in men and women.
• Estrogen or testosterone replacement therapy can restore hormone levels.
• Blood tests assess hormone levels crucial for sexual health evaluation.
• Supplements like L-arginine may improve erectile function via increased nitric oxide.
• Zinc deficiency can impair sexual function and is sometimes supplemented.
• Herbal remedies claim to enhance libido but require scientific validation.
• Vitamin D deficiency has been linked to lower testosterone levels.
• Lifestyle modifications often complement pharmaceutical treatments.

[29] Though it is not approved by the US FDA owing to its toxicity, it has been approved by Canada and a plethora of countries in Europe with the brand name Androcur in the market.

Can Vacuum Devices Help With Erectile Dysfunction?

[23] Marked as VyleesiTM, it was primarily designed for both men and women in the form of an intranasal formulation, particularly for treating male erectile dysfunction. [23] However, the research was discontinued and focused on targeting female HSDD[23] in a subcutaneous injection to increase bioavailability. [3] Bremelanotide is usually injected a minimum of 45 minutes before sexual activity. Despite having identical prescription criteria as that of flibanserin, bremelanotide is not recommended for pregnant patients. No trial was tested on pregnant patients.

Direct mechanism

[24] Therefore, patients at childbearing ages are recommended to use contraception continuously during treatment and should discontinue once they become pregnant. The melanocortin receptor agonist proposes to activate multiple receptor subtypes nonselectively, with the highest affinity with MC1R, then MC4R, MC3R, MC5R, and MC2R receptors. [23] As MC4R receptors are present on neurons in the central nervous system, a function in modulating brain pathways is suggested, albeit a precise mechanism remains unknown. Sustained and significant improvement in FSFI scores throughout a 52-week extension was attained, indicating a high efficacy of the drug treating HSDD, most notably when anticipating the challenge in psychological distress. Mild or moderate adverse events are common, expressing symptoms like nausea, facial flushing, headache, and sunburn. [29][38][39] This drug mainly targets men due to its mechanism of action. Cyproterone acetate suppresses libido by directly reducing the level of active androgen, testosterone, in males. The suppression of testosterone level results from its inhibition of the release of luteinizing hormone (LH) from the anterior section of the pituitary gland, interfering with testosterone production from the testes as LH stimulates testosterone production. [32][39][40] tadacip 20 tablet It also blocks the conversion of testosterone to dihydrotestosterone for action.

[38][41] In addition to this mechanism, it also competes for the androgen receptors against testosterone and dihydrotestosterone, causing interference with the androgen-receptor interaction on the reproductive organ, thereby lowering sexual desire. Cyproterone acetate has been proven effective in restraining sexual drive and fantasies in patients with high libido. [5] Its usage in treating hypersexuality has been advocated by the World Federation of Societies of Biological Psychiatry (WFSBP). Common adverse effects of cyproterone acetate include depression, hepatotoxicity, dyspnea, change in body weight, hot flushes, sweating, fatigue, and gynaecomastia. Cyproterone acetate is mainly orally administered to the body, and it has a half-life of 1.8 days. [29][39][42] After metabolism, its metabolites are predominantly excreted via faeces. There are many types of drugs that unintentionally lower sexual desire through indirect mechanisms. It is one of their side-effects as the outcome of libido suppression is not intended. SSRIs reduce the re-uptake of serotonin back to the neurons, leading to an increase in serotonin level in the body. Due to the fact that serotonin can interfere with other neurotransmitters and hormones, for instance, sex hormones, SSRIs can therefore lower sexual desire.

• Medication combined with psychotherapy can be effective for sexual health issues.
• Serotonin reuptake inhibitors are sometimes used off-label to treat sexual dysfunction.
• Side effects of sex medications can include headache, flushing, or nasal congestion.
• Proper diagnosis of underlying conditions is key to effective sexual medicine treatments.
• Drug interactions may affect the efficacy and safety of sexual medications.
• The stigma around sexual medicine can hinder individuals from seeking help.
• Emerging treatments include stem cell therapy for erectile tissue regeneration.
• Clinical trials are ongoing to find new solutions for sexual dysfunction.

Apart from SSRIs, other types of drugs that could lower sexual desire are not intended to suppress libido originally. Thus, sexually active people are suggested to avoid the usage of the following drugs:[44] Non-steroidal anti-inflammatory drugs (e.g. Postmenopausal women may also suffer from HSDD due to a decline in androgen production from menopause. [6] A research proposed two combinations of drugs, each designed against the different causes of HSDD.

The bottom line

They are synthesized by replacing the sixth and tenth amino acids of the original gonadotropin-releasing peptide hormone. [28] After the modification, they can bind to the GnRH receptors more strongly and are less degradable by enzymes when compared to the natural GnRH, making them more biologically active. [28][29] GnRH agonists commonly used are leuprorelin, goserelin, and triptorelin, which are marked as Lupron, Zoladex, and Decapetyl, respectively. [30] Nafarelin, marked as Synarel, is also occasionally prescribed in the vardenafil 5 mg form of nasal spray. [31] These drugs are all approved by the US FDA, and their working principles target both sexes equally.

Sexual techniques

This class of drugs initially stimulates the anterior pituitary gland to secrete more GnRH, leading to a temporary surge in GnRH level in the circulation. [32] Yet, because of the desensitization effect on the receptors upon continuous stimulation, in the long term, its secretion will be inhibited if continual medication is prescribed. [28][32][33] Particularly, GnRH is essential for the release of gonadotropic hormones, such as LH and follicle-stimulating hormone (FSH), from the anterior pituitary-body. These hormones are responsible for the synthesis of steroid sex hormones (testosterone in men; progesterone and estrogen in women). Therefore, GnRH inhibition by these drugs, in turn, reduces the secretion of steroid sex hormones from the sex organs, eventually leading to libido suppression. One combination is to utilise sublingual testosterone with a 5-HT1A receptor agonist to raise motivation for sex, by lifting the inhibition mechanisms in the brain's prefrontal regions.

[6][7][8] Testosterone is also proposed to be coupled with the PDE5 inhibitor, targeting an insensitive system for the production of sexual desire. [6][7][8] As both clinical trials showed desirable results, this indicates the prosperity of further developing a single drug targeting HSDD for all women of different status, even though the FDA has not approved the two combinations. In fact, HSDD was defined shortly before the release of flibanserin to the market and its approval by the US FDA. This has brought up a controversy about whether it is appropriate and ethical to create a medical condition for the benefit of the sales of pharmaceutical products.

• Sexual dysfunction can be a symptom of underlying health issues.
• Psychological factors like depression can reduce sexual desire.
• Medications for depression may cause sexual side effects.
• Lifestyle changes can improve mental health and sexual function.
• Support groups provide emotional help related to sexual health problems.
• Sexual therapy addresses emotional and relational challenges.
• Educational programs can dispel myths and promote healthy sexual practices.
• Partner communication is key to resolving many sexual medicine issues.

Apart from this ethical issue, there is a dilemma of whether a medical doctor should prescribe drugs to sexual offenders whose libido is subpar. On the one hand, it is considered unethical for doctors not to treat them as they are expected to treat patients indiscriminately. On the other hand, treating sexual offenders may impose a risk to society.

What are the risk factors for erectile dysfunction?

Many studies have shown that leuprorelin, goserelin and triptorelin are effective in suppressing sexual desires and increasing control against sex. [5] Patients who were prescribed with these drugs have sexual thoughts less frequently and strongly. Common adverse effects elicited by these drugs include hot flushes, bone loss, headache, unpredictable mood changes, depression, vaginal dryness, or even atrophy for females and penile atrophy for males. [34] These adverse effects can be counteracted and treated by add-back therapy, also known as hormone replacement therapy. People treated with GnRH agonists are suggested to undergo this therapy simultaneously by taking adequate progestin, vitamin D, and calcium supplement pills daily.

ED overview

Gonadotropin-releasing hormone agonists are largely parenterally administered to the body, that is, via subcutaneous or intramuscular injection. [30][32][35][36][37] At the same time, nafarelin is an exception in which its prescription is a nasal spray, and some may be implanted into fats. [31] In general, their half-lives are approximately two to four hours. [31][35][36][37] Some agonists are mainly excreted via urine while other agonists are mainly excreted via faeces. Steroidal anti-androgens are a class of steroid drugs that inhibit the actions of androgens. Physicians have been struggling with this dilemma, and it is still difficult for them to make a choice at this moment in time.

• Erectile dysfunction affects approximately 1 in 10 men worldwide.
• Female sexual arousal disorder has complex psychological and physiological roots.
• Aging naturally impacts sexual performance; treatments can mitigate effects.
• Psychological factors like guilt or fear can inhibit sexual response.
• Partner support improves treatment adherence and outcomes.
• Open communication about desires and concerns enhances sexual satisfaction.
• Medications should be taken under professional supervision to ensure safety.
• Research continues to develop more effective, side-effect-free therapies.

"Mechanism of action of flibanserin, a multifunctional serotonin agonist and antagonist (MSAA), in hypoactive sexual desire disorder". "Brain Mechanisms of Sexual Desire, Pleasure, And Inhibition". "Bremelanotide: New Drug Approved for Treating Hypoactive Sexual Desire Disorder".

The Big Pink Fight for the Little Pink Pill

[3][23] Unlike flibanserin, bremelanotide induces fewer side effects and is not affected nor develops severe complications with alcohol. [20] However, the drug slows down gastric emptying, which can cause an impact on oral drug uptake and the subsequent drug effectiveness. [24] As activation of MC1R gives rise to hyperpigmentation,[3] treatment dosage is at a maximum of eight doses per month. [24] Besides, to minimize the chances of cardiovascular complications, the prescribed daily dosage is at one dose. Bremelanotide is exposed through a single subcutaneous administration.

IN CLINICAL TRIALS1, WOMEN ON ADDYI EXPERIENCED:

[26] With a half-life of an hour, the drug is excreted through urine and faeces. Since HSDD in men is not acknowledged and was categorized to be a distinct sexual dysfunction,[4] there are currently no drugs specialized for men in similar conditions as stated above. Drugs down-regulating libido are generally either intended for libido suppression via direct down-regulating mechanisms or eliciting such side-effects by their unintended indirect mechanisms. Two types of drugs are mainly prescribed to people suffering from overwhelming sexual desire: gonadotropin-releasing hormone agonists (GnRH agonists) and steroidal anti-androgens. GnRH agonists are a group of drugs intended to activate GnRH receptors in the anterior pituitary gland. ^ a b c DeRogatis, Leonard; Rosen, Raymond C.; Goldstein, Irwin; Werneburg, Brian; Kempthorne-Rawson, Joan; Sand, Michael (March 2012). "Characterization of Hypoactive Sexual Desire Disorder (HSDD) in Men". "Treatment of Paraphilic Disorders in Sexual Offenders or Men With a Risk of Sexual Offending With Luteinizing Hormone-Releasing Hormone Agonists: An Updated Systematic Review".